UBS Group AG Has $12.88 Million Stock Holdings in ASP Isotopes Inc. $ASPI

UBS Group AG increased its holdings in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 150.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,406,457 shares of the company’s stock after buying an additional 1,445,165 shares during the quarter. UBS Group AG owned 2.17% of ASP Isotopes worth $12,875,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of ASPI. Marshall Wace LLP increased its holdings in shares of ASP Isotopes by 3,669.1% in the 3rd quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock valued at $12,305,000 after purchasing an additional 1,245,184 shares during the period. Vanguard Group Inc. lifted its position in ASP Isotopes by 37.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after buying an additional 1,241,024 shares in the last quarter. Rovida Investment Management Ltd boosted its stake in shares of ASP Isotopes by 45.5% during the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after buying an additional 1,000,000 shares during the period. Jump Financial LLC purchased a new position in shares of ASP Isotopes during the 3rd quarter valued at $8,990,000. Finally, Squarepoint Ops LLC acquired a new position in shares of ASP Isotopes in the third quarter worth $6,011,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Trading Down 3.6%

ASP Isotopes stock opened at $6.09 on Friday. ASP Isotopes Inc. has a one year low of $3.92 and a one year high of $14.49. The company’s fifty day moving average price is $5.09 and its two-hundred day moving average price is $6.14. The company has a debt-to-equity ratio of 0.77, a current ratio of 12.23 and a quick ratio of 12.20. The company has a market capitalization of $766.73 million, a price-to-earnings ratio of -2.85 and a beta of 3.26.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Friday, April 10th. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.70). ASP Isotopes had a negative return on equity of 161.55% and a negative net margin of 734.14%.The company had revenue of $33.32 million for the quarter, compared to the consensus estimate of $2.03 million.

Insider Activity

In other news, COO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $4.51, for a total value of $112,750.00. Following the completion of the sale, the chief operating officer directly owned 1,512,817 shares in the company, valued at approximately $6,822,804.67. The trade was a 1.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52. Following the sale, the chief financial officer directly owned 709,376 shares of the company’s stock, valued at approximately $3,887,380.48. This represents a 3.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 90,704 shares of company stock valued at $463,252 over the last 90 days. 14.40% of the stock is currently owned by company insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.